Natera

YTD

ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).

CEO

Stephen Leonard Chapman

CEOStephen Leonard Chapman

Employees

6,140

Employees6,140

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2003

Founded2003

Employees

6,140

Employees6,140

NTRA Key Statistics

Market cap

31.15B

Market cap31.15B

Price-Earnings ratio

-143.05

Price-Earnings ratio-143.05

Dividend yield

—

Dividend yield—

Average volume

1.47M

Average volume1.47M

High today

$219.85

High today$219.85

Low today

$219.85

Low today$219.85

Open price

$215.50

Open price$215.50

Volume

332.00

Volume332.00

52 Week high

$256.36

52 Week high$256.36

52 Week low

$131.81

52 Week low$131.81

Stock Snapshot

As of today, Natera(NTRA) shares are valued at $219.85. The company's market cap stands at 31.15B, with a P/E ratio of -143.05.

On 2026-05-08, Natera(NTRA) stock moved within a range of $219.85 to $219.85. With shares now at $219.85, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading volume for Natera(NTRA) stock has reached 332, versus its average volume of 1.47M.

Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $256.36 and a low of $131.81.

NTRA News

TipRanks 8h

Natera: Strong Q1 Beat, Raised Guidance Support Buy Rating with Unchanged $280 Price Target

TD Cowen analyst Daniel Brennan maintained a Buy rating on Natera yesterday and set a price target of $280.00. Claim 55% Off TipRanks Unlock hedge fund-level da...

The Motley Fool 14h

Natera NTRA Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Steve Chapman President, Clinical Diagnostics...

Simply Wall St 4d

Have Insiders Sold Natera Shares Recently?

We wouldn't blame Natera, Inc. ( ) shareholders if they were a little worried about the fact that Steven Chapman, the CEO & Director recently netted about US$1....

Analyst ratings

90%

of 20 ratings

Buy

90%

Hold

10%

Sell

More NTRA News

Simply Wall St 7d

Extreme Networks And 2 Additional Stocks Estimated To Be Trading Below Their Fair Value

In the last week, the United States market has stayed flat, yet it is up 29% over the past year with earnings forecasted to grow by 16% annually. In such a clim...

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Fluor

Flowserve

iShares MSCI Emerging Mar…

KLA

ResMed

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.